BRIEF-Amarin reduces it cardiovascular outcomes study of Vascepa By: Reuters: Company News September 12, 2016 at 05:59 AM EDT * It cardiovascular outcomes study of Vascepa to continue as planned at recommendation of independent data monitoring committee Read More >> Related Stocks: Amarin Corp ADR